Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Allarity Therapeutics, Inc. - Common stock (NQ: ALLR ) 0.1441 -0.0239 (-14.23%) Streaming Delayed Price Updated: 10:18 AM EDT, Jul 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Allarity Therapeutics, Inc. - Common stock < Previous 1 2 3 4 5 6 7 8 9 10 Next > 12 Health Care Stocks Moving In Wednesday's Intraday Session June 07, 2023 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session June 07, 2023 Via Benzinga Stocks That Hit 52-Week Lows On Tuesday June 06, 2023 On Tuesday, 69 stocks hit new 52-week lows. Via Benzinga Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session May 30, 2023 Gainers QualTek Services Inc. (NASDAQ: QTEK) shares jumped 127.2% to $0.1740 after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter 11 bankruptcy. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session May 30, 2023 Via Benzinga Why Seelos Therapeutics Shares Are Trading Lower By 10%; Here Are 20 Stocks Moving Premarket May 30, 2023 Gainers QualTek Services Inc. (NASDAQ: QTEK) shares rose 206.7% to $0.2350 in pre-market trading after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter... Via Benzinga First Prospective Clinical Validation of Allarity's DRP® Companion Diagnostic to be Presented at 2023 ASCO Annual Meeting May 30, 2023 From Allarity Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Monday's After-Market Session May 29, 2023 Via Benzinga Allarity Therapeutics Accelerates Trial Enrollment To Bring FDA-Approved Breast Cancer Treatment To European Market - Interim Results Could Be Released In Second Half Of 2023 April 27, 2023 Via ACCESSWIRE Allarity Therapeutics Accelerates Trial Enrollment To Bring FDA-Approved Breast Cancer Treatment To European Market – Interim Results Could Be Released In Second Half Of 2023 April 26, 2023 Recently, Allarity Therapeutics, Inc. (NASDAQ: ALLR) announced plans to speed up its Phase 2 clinical trial for IXEMPRA®, the clini Via Benzinga Why SAP Shares Are Trading Higher By Around 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session April 21, 2023 Gainers Mangoceuticals, Inc. (NASDAQ: MGRX) shares jumped 207% to $2.84. The company announced Thursday, that it's featured on Webull Corporate Communications Service Platform. Via Benzinga Nasdaq Edges Higher; Abbott Laboratories Reports Upbeat Results April 19, 2023 U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Wednesday. The Dow traded down 0.23% to 33,899.20 while the NASDAQ rose 0.16% to 12,172.92. The S&P 500,... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session April 19, 2023 Via Benzinga Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session April 19, 2023 Gainers China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 85.2% to $1.25 after the company announced the termination of its previously proposed registered direct offering. Via Benzinga Virax Biolabs (VRAX) Stock Soars on PCR Test DIstribution Agreement April 19, 2023 Virax Biolabs (VRAX) stock is on the rise Wednesday after the company secured a Marburg Virus Real Time PCR Kit distribution deal. Via InvestorPlace LUNR Stock Alert: The $719 Million Reason Intuitive Machines Is Rising Today April 19, 2023 Intuitive Machines (LUNR) stock is heading higher on Wednesday thanks to news of a $719 million, five-year award from NASA. Via InvestorPlace Allarity Therapeutics, Inc. Announces Pricing of $7.5 Million Public Offering April 19, 2023 From Allarity Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's Pre-Market Session April 19, 2023 Via Benzinga Why Is Gamida Cell (GMDA) Stock Down 19% Today? April 19, 2023 Gamida Cell (GMDA) stock is falling on Wednesday after the cell therapy company revealed details of a public securities offering. Via InvestorPlace Why Is Allarity Therapeutics (ALLR) Stock Down 22% Today? April 19, 2023 Allarity Therapeutics (ALLR) stock is falling hard on Wednesday after the clinical-stage pharmaceutical company launched a public offering. Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday April 19, 2023 It's time for another dive into the biggest pre-market stock movers traders will want to know about on Wednesday morning! Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's Intraday Session April 18, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session April 18, 2023 Via Benzinga Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 18, 2023 Gainers Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) shares jumped 122% to $1.07 after the company announced the signing of a $60 million strategic investment with two institutional... Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session April 17, 2023 Via Benzinga This Combination Therapy Could Help Change Cancer Treatment - Take A Deeper Look Into Allarity Therapeutics' Trial April 17, 2023 Via ACCESSWIRE Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session April 17, 2023 Gainers ContraFect Corporation (NASDAQ: CFRX) shares surged 213% to $2.82. Via Benzinga 7 Sorry Pharma Stocks to Sell in April Before It’s Too Late April 16, 2023 You have to be patient when investing in pharma stocks. But sometimes the risk and the wait aren't worth the rewards. Via InvestorPlace 12 Health Care Stocks Moving In Friday's Intraday Session April 14, 2023 Via Benzinga This Combination Therapy Could Help Change Cancer Treatment — Benzinga Looks Deeper Into Allarity Therapeutics' Trial, Including An Interview With An Oncology Expert April 13, 2023 Allarity Therapeutics (NASDAQ: ALLR) dosed its first patient in Phase 1b of its clinical trial for the novel combination therapy of two drug Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 10 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.